ADI
ADI
Fundamental comparison between ADI and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
ADI
Injective
Detailed Comparison
| Metric | ADI | Injective |
|---|---|---|
| Price | $6.95 | $4.81 |
| Market Cap | $65.19M | $480.89M |
| 24h Volume | 5M | 61.9M |
| Rank | #— | #— |
| Circulating Supply | 9.4M | 100M |
| ATH | $8.72 | $52.62 |
ADI vs Injective — Analysis
ADI and Injective are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 47.1, ADI is currently rated as "fair value", while Injective scores 70.7 and is rated "undervalued". This means our algorithm considers Injective the fundamentally stronger investment — with a significant gap of 23.6 points.
Market Cap & Risk
Injective has a 7x larger market capitalization than ADI. A larger market cap typically means less volatility but also less growth potential. ADI may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, ADI moved 0.30%, while Injective changed 4.90%. Looking at the 7-day window, ADI is at -0.20% and Injective at -7.90%.
Distance from All-Time High
ADI currently trades at 80% of its all-time high ($8.72), while Injective sits at 9% of its ATH ($52.62). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than ADI (Score: 47.1). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
